248 related articles for article (PubMed ID: 23785463)
1. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
Burton JP; Wescombe PA; Macklaim JM; Chai MH; Macdonald K; Hale JD; Tagg J; Reid G; Gloor GB; Cadieux PA
PLoS One; 2013; 8(6):e65991. PubMed ID: 23785463
[TBL] [Abstract][Full Text] [Related]
2. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.
Heng NC; Haji-Ishak NS; Kalyan A; Wong AY; Lovric M; Bridson JM; Artamonova J; Stanton JA; Wescombe PA; Burton JP; Cullinan MP; Tagg JR
J Bacteriol; 2011 Nov; 193(22):6402-3. PubMed ID: 22038965
[TBL] [Abstract][Full Text] [Related]
3. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Wescombe PA; Burton JP; Cadieux PA; Klesse NA; Hyink O; Heng NC; Chilcott CN; Reid G; Tagg JR
Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
[TBL] [Abstract][Full Text] [Related]
4. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial.
Burton JP; Drummond BK; Chilcott CN; Tagg JR; Thomson WM; Hale JDF; Wescombe PA
J Med Microbiol; 2013 Jun; 62(Pt 6):875-884. PubMed ID: 23449874
[TBL] [Abstract][Full Text] [Related]
5. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
Wescombe PA; Upton M; Dierksen KP; Ragland NL; Sivabalan S; Wirawan RE; Inglis MA; Moore CJ; Walker GV; Chilcott CN; Jenkinson HF; Tagg JR
Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
[TBL] [Abstract][Full Text] [Related]
6. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
Barbour A; Philip K
PLoS One; 2014; 9(6):e100541. PubMed ID: 24941127
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
[TBL] [Abstract][Full Text] [Related]
8. Genome sequence of the lantibiotic bacteriocin producer Streptococcus salivarius strain K12.
Barretto C; Alvarez-Martin P; Foata F; Renault P; Berger B
J Bacteriol; 2012 Nov; 194(21):5959-60. PubMed ID: 23045482
[TBL] [Abstract][Full Text] [Related]
9. Randomized Clinical Trial of Oral Probiotic
Salim HP; Mallikarjun SB; Raju S; Surendranath AR
Int J Clin Pediatr Dent; 2023; 16(2):259-263. PubMed ID: 37519958
[TBL] [Abstract][Full Text] [Related]
10. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.
Wescombe PA; Upton M; Renault P; Wirawan RE; Power D; Burton JP; Chilcott CN; Tagg JR
Microbiology (Reading); 2011 May; 157(Pt 5):1290-1299. PubMed ID: 21310787
[TBL] [Abstract][Full Text] [Related]
11. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
12. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.
Hyink O; Wescombe PA; Upton M; Ragland N; Burton JP; Tagg JR
Appl Environ Microbiol; 2007 Feb; 73(4):1107-13. PubMed ID: 17194838
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial effect of probiotic bacteriocins on
Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
[TBL] [Abstract][Full Text] [Related]
14. Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
Sarlin S; Tejesvi MV; Turunen J; Vänni P; Pokka T; Renko M; Tapiainen T
Pediatr Infect Dis J; 2021 May; 40(5):394-402. PubMed ID: 33298762
[TBL] [Abstract][Full Text] [Related]
15. Safety assessment of
Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
[TBL] [Abstract][Full Text] [Related]
16. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.
Wescombe PA; Heng NC; Burton JP; Chilcott CN; Tagg JR
Future Microbiol; 2009 Sep; 4(7):819-35. PubMed ID: 19722837
[TBL] [Abstract][Full Text] [Related]
17. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota.
Riboulet-Bisson E; Sturme MH; Jeffery IB; O'Donnell MM; Neville BA; Forde BM; Claesson MJ; Harris H; Gardiner GE; Casey PG; Lawlor PG; O'Toole PW; Ross RP
PLoS One; 2012; 7(2):e31113. PubMed ID: 22363561
[TBL] [Abstract][Full Text] [Related]
18. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
Santagati M; Scillato M; Patanè F; Aiello C; Stefani S
FEMS Immunol Med Microbiol; 2012 Jun; 65(1):23-31. PubMed ID: 22243526
[TBL] [Abstract][Full Text] [Related]
19. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.
Burton JP; Wescombe PA; Moore CJ; Chilcott CN; Tagg JR
Appl Environ Microbiol; 2006 Apr; 72(4):3050-3. PubMed ID: 16598017
[TBL] [Abstract][Full Text] [Related]
20. The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.
Dierksen KP; Moore CJ; Inglis M; Wescombe PA; Tagg JR
FEMS Microbiol Ecol; 2007 Mar; 59(3):584-91. PubMed ID: 17069620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
